106 related articles for article (PubMed ID: 17283222)
1. The hepatocyte nuclear factor 6 (HNF6) and FOXA2 are key regulators in colorectal liver metastases.
Lehner F; Kulik U; Klempnauer J; Borlak J
FASEB J; 2007 May; 21(7):1445-62. PubMed ID: 17283222
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the liver enriched protein FOXA2 recovers HNF6 activity in human colon carcinoma and liver hepatoma cells.
Lehner F; Kulik U; Klempnauer J; Borlak J
PLoS One; 2010 Oct; 5(10):e13344. PubMed ID: 20967225
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional networks in the liver: hepatocyte nuclear factor 6 function is largely independent of Foxa2.
Rubins NE; Friedman JR; Le PP; Zhang L; Brestelli J; Kaestner KH
Mol Cell Biol; 2005 Aug; 25(16):7069-77. PubMed ID: 16055718
[TBL] [Abstract][Full Text] [Related]
4. Mapping of liver-enriched transcription factors in the human intestine.
Lehner F; Kulik U; Klempnauer J; Borlak J
World J Gastroenterol; 2010 Aug; 16(31):3919-27. PubMed ID: 20712053
[TBL] [Abstract][Full Text] [Related]
5. Foxa2 (HNF-3beta) regulates expression of hepatotrophic factor ALR in liver cells.
Dayoub R; Groitl P; Dobner T; Bosserhoff AK; Schlitt HJ; Weiss TS
Biochem Biophys Res Commun; 2010 May; 395(4):465-70. PubMed ID: 20382118
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage.
Koehler A; Bataille F; Schmid C; Ruemmele P; Waldeck A; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
J Pathol; 2004 Sep; 204(1):65-74. PubMed ID: 15307139
[TBL] [Abstract][Full Text] [Related]
7. The cut-homeodomain transcriptional activator HNF-6 is coexpressed with its target gene HNF-3 beta in the developing murine liver and pancreas.
Rausa F; Samadani U; Ye H; Lim L; Fletcher CF; Jenkins NA; Copeland NG; Costa RH
Dev Biol; 1997 Dec; 192(2):228-46. PubMed ID: 9441664
[TBL] [Abstract][Full Text] [Related]
8. HNF6 promotes tumor growth in colorectal cancer and enhances liver metastasis in mouse model.
Jiang K; Jiao Y; Liu Y; Fu D; Geng H; Chen L; Chen H; Shen X; Sun L; Ding K
J Cell Physiol; 2019 Apr; 234(4):3675-3684. PubMed ID: 30256389
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hepatitis B virus gene expression and replication by hepatocyte nuclear factor 6.
Hao R; He J; Liu X; Gao G; Liu D; Cui L; Yu G; Yu W; Chen Y; Guo D
J Virol; 2015 Apr; 89(8):4345-55. PubMed ID: 25653429
[TBL] [Abstract][Full Text] [Related]
10. C/EBPalpha and HNF6 protein complex formation stimulates HNF6-dependent transcription by CBP coactivator recruitment in HepG2 cells.
Yoshida Y; Hughes DE; Rausa FM; Kim IM; Tan Y; Darlington GJ; Costa RH
Hepatology; 2006 Feb; 43(2):276-86. PubMed ID: 16440369
[TBL] [Abstract][Full Text] [Related]
11. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
[TBL] [Abstract][Full Text] [Related]
12. A vHNF1/TCF2-HNF6 cascade regulates the transcription factor network that controls generation of pancreatic precursor cells.
Poll AV; Pierreux CE; Lokmane L; Haumaitre C; Achouri Y; Jacquemin P; Rousseau GG; Cereghini S; Lemaigre FP
Diabetes; 2006 Jan; 55(1):61-9. PubMed ID: 16380477
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone regulates the expression of hepatocyte nuclear factor-3 gamma and other liver-enriched transcription factors in the bovine liver.
Eleswarapu S; Jiang H
J Endocrinol; 2005 Jan; 184(1):95-105. PubMed ID: 15642787
[TBL] [Abstract][Full Text] [Related]
14. Stability of the hepatocyte nuclear factor 6 transcription factor requires acetylation by the CREB-binding protein coactivator.
Rausa FM; Hughes DE; Costa RH
J Biol Chem; 2004 Oct; 279(41):43070-6. PubMed ID: 15304484
[TBL] [Abstract][Full Text] [Related]
15. Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain.
Stange DE; Engel F; Longerich T; Koo BK; Koch M; Delhomme N; Aigner M; Toedt G; Schirmacher P; Lichter P; Weitz J; Radlwimmer B
Gut; 2010 Sep; 59(9):1236-44. PubMed ID: 20479215
[TBL] [Abstract][Full Text] [Related]
16. Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases.
Gentner B; Wein A; Croner RS; Zeittraeger I; Wirtz RM; Roedel F; Dimmler A; Dorlaque L; Hohenberger W; Hahn EG; Brueckl WM
Anticancer Res; 2009 Jan; 29(1):67-74. PubMed ID: 19331134
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor messenger RNA expression level is preserved in liver metastases compared with corresponding primary colorectal cancer.
Kuramochi H; Hayashi K; Uchida K; Miyakura S; Shimizu D; Vallböhmer D; Park S; Danenberg KD; Takasaki K; Danenberg PV
Clin Cancer Res; 2006 Jan; 12(1):29-33. PubMed ID: 16397020
[TBL] [Abstract][Full Text] [Related]
18. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.
Xu L; Hui L; Wang S; Gong J; Jin Y; Wang Y; Ji Y; Wu X; Han Z; Hu G
Cancer Res; 2001 Apr; 61(7):3176-81. PubMed ID: 11306505
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
[TBL] [Abstract][Full Text] [Related]
20. Growth Hormone Mediates Its Protective Effect in Hepatic Apoptosis through Hnf6.
Wang K; Wang M; Gannon M; Holterman A
PLoS One; 2016; 11(12):e0167085. PubMed ID: 27936029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
